Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Allergens | 6 | 2018 | 728 | 1.24 | Why? |
| Arthropod Venoms | 2 | 2017 | 27 | 0.89 | Why? |
| Hymenoptera | 2 | 2017 | 13 | 0.87 | Why? |
| Immunoglobulin E | 5 | 2018 | 557 | 0.81 | Why? |
| Receptors, Interleukin-10 | 1 | 2019 | 3 | 0.80 | Why? |
| Desensitization, Immunologic | 4 | 2020 | 574 | 0.73 | Why? |
| Langerhans Cells | 1 | 2017 | 14 | 0.72 | Why? |
| Adoptive Transfer | 1 | 2018 | 250 | 0.65 | Why? |
| Hypersensitivity | 4 | 2018 | 1137 | 0.58 | Why? |
| Dermatitis, Allergic Contact | 1 | 2018 | 185 | 0.57 | Why? |
| Immune Tolerance | 1 | 2019 | 608 | 0.52 | Why? |
| Bee Venoms | 3 | 2018 | 43 | 0.52 | Why? |
| Interleukin-10 | 1 | 2019 | 1409 | 0.46 | Why? |
| Hypersensitivity, Immediate | 1 | 2012 | 134 | 0.43 | Why? |
| Dendritic Cells | 1 | 2019 | 1330 | 0.40 | Why? |
| Urticaria | 4 | 2017 | 472 | 0.40 | Why? |
| Wasp Venoms | 2 | 2018 | 6 | 0.31 | Why? |
| Omalizumab | 3 | 2017 | 158 | 0.31 | Why? |
| Wasps | 2 | 2018 | 9 | 0.31 | Why? |
| Skin | 1 | 2018 | 2096 | 0.30 | Why? |
| Dermatitis, Atopic | 3 | 2021 | 714 | 0.26 | Why? |
| Anti-Allergic Agents | 2 | 2017 | 167 | 0.25 | Why? |
| Signal Transduction | 1 | 2019 | 7207 | 0.23 | Why? |
| Anaphylaxis | 2 | 2021 | 940 | 0.22 | Why? |
| T-Lymphocytes | 1 | 2018 | 6670 | 0.21 | Why? |
| Asthma | 2 | 2019 | 4383 | 0.20 | Why? |
| Insect Bites and Stings | 3 | 2018 | 63 | 0.20 | Why? |
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2019 | 13 | 0.20 | Why? |
| Immunity, Innate | 1 | 2018 | 6570 | 0.20 | Why? |
| Insect Proteins | 1 | 2018 | 39 | 0.18 | Why? |
| Receptors, IgE | 1 | 2018 | 26 | 0.18 | Why? |
| Bees | 1 | 2018 | 41 | 0.18 | Why? |
| Diphosphonates | 1 | 2019 | 121 | 0.18 | Why? |
| Blepharitis | 1 | 2017 | 4 | 0.18 | Why? |
| Clindamycin | 1 | 2018 | 59 | 0.18 | Why? |
| Carbohydrates | 1 | 2018 | 51 | 0.18 | Why? |
| Antibodies, Anti-Idiotypic | 2 | 2018 | 93 | 0.17 | Why? |
| Histamine H1 Antagonists | 1 | 2017 | 79 | 0.16 | Why? |
| Bone Density Conservation Agents | 1 | 2019 | 209 | 0.16 | Why? |
| Immunoassay | 1 | 2012 | 4485 | 0.16 | Why? |
| Conjunctivitis, Allergic | 1 | 2017 | 94 | 0.16 | Why? |
| Cross Reactions | 2 | 2018 | 4374 | 0.15 | Why? |
| Keratitis | 1 | 2017 | 102 | 0.15 | Why? |
| Bone Neoplasms | 1 | 2019 | 287 | 0.15 | Why? |
| Biological Assay | 1 | 2017 | 367 | 0.13 | Why? |
| Mice, Knockout | 1 | 2019 | 1815 | 0.13 | Why? |
| Drug Eruptions | 1 | 2018 | 319 | 0.13 | Why? |
| Animals | 9 | 2019 | 78931 | 0.13 | Why? |
| Drug Hypersensitivity | 1 | 2018 | 401 | 0.11 | Why? |
| Skin Tests | 1 | 2012 | 229 | 0.11 | Why? |
| Disease Models, Animal | 2 | 2019 | 10998 | 0.10 | Why? |
| Mice | 2 | 2019 | 21357 | 0.09 | Why? |
| Immunization | 1 | 2017 | 2019 | 0.09 | Why? |
| Antibody Specificity | 1 | 2012 | 1328 | 0.09 | Why? |
| Precision Medicine | 1 | 2017 | 1477 | 0.08 | Why? |
| Epitopes | 1 | 2018 | 4113 | 0.07 | Why? |
| Universities | 1 | 2020 | 4374 | 0.07 | Why? |
| Risk | 1 | 2017 | 5288 | 0.07 | Why? |
| Sensitivity and Specificity | 2 | 2017 | 22971 | 0.07 | Why? |
| Dermatology | 1 | 2019 | 1999 | 0.06 | Why? |
| Patient Safety | 1 | 2018 | 4885 | 0.06 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.06 | Why? |
| Adaptor Proteins, Signal Transducing | 1 | 2005 | 502 | 0.06 | Why? |
| Breast Neoplasms | 1 | 2019 | 3633 | 0.05 | Why? |
| Humans | 22 | 2021 | 930598 | 0.05 | Why? |
| Baculoviridae | 1 | 2018 | 132 | 0.04 | Why? |
| Sf9 Cells | 1 | 2018 | 273 | 0.04 | Why? |
| Polymorphism, Genetic | 1 | 2005 | 1074 | 0.04 | Why? |
| Patch Tests | 1 | 2018 | 114 | 0.04 | Why? |
| Chronic Disease | 3 | 2017 | 5139 | 0.04 | Why? |
| Network Meta-Analysis | 1 | 2019 | 426 | 0.04 | Why? |
| Inflammation | 1 | 2019 | 13255 | 0.04 | Why? |
| Histamine Antagonists | 1 | 2017 | 203 | 0.04 | Why? |
| PubMed | 1 | 2017 | 246 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Patient Reported Outcome Measures | 1 | 2020 | 912 | 0.04 | Why? |
| Cloning, Molecular | 1 | 2018 | 1036 | 0.04 | Why? |
| Drug Resistance | 1 | 2017 | 395 | 0.03 | Why? |
| Female | 9 | 2020 | 380317 | 0.03 | Why? |
| Immunoglobulin Fc Fragments | 1 | 2018 | 691 | 0.03 | Why? |
| Male | 8 | 2020 | 367725 | 0.03 | Why? |
| Germany | 2 | 2019 | 9196 | 0.03 | Why? |
| Learning | 1 | 2020 | 1181 | 0.03 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2013 | 9335 | 0.03 | Why? |
| Teaching | 1 | 2020 | 1208 | 0.03 | Why? |
| Single-Domain Antibodies | 1 | 2018 | 744 | 0.03 | Why? |
| Genetic Predisposition to Disease | 1 | 2005 | 4027 | 0.03 | Why? |
| Crystallography, X-Ray | 1 | 2018 | 2689 | 0.03 | Why? |
| Adjuvants, Immunologic | 1 | 2019 | 1709 | 0.02 | Why? |
| Quality of Life | 2 | 2019 | 9820 | 0.02 | Why? |
| Protein Conformation | 1 | 2018 | 4386 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2017 | 2259 | 0.02 | Why? |
| Nod1 Signaling Adaptor Protein | 1 | 2005 | 23 | 0.02 | Why? |
| Treatment Outcome | 3 | 2017 | 51732 | 0.02 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.02 | Why? |
| Japan | 1 | 2019 | 6653 | 0.02 | Why? |
| Binding Sites | 1 | 2018 | 6201 | 0.02 | Why? |
| Linkage Disequilibrium | 1 | 2005 | 191 | 0.02 | Why? |
| Adolescent | 4 | 2020 | 86841 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2017 | 3228 | 0.02 | Why? |
| Models, Molecular | 1 | 2018 | 7616 | 0.02 | Why? |
| Middle Aged | 6 | 2020 | 270681 | 0.02 | Why? |
| Internet | 1 | 2020 | 6204 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.01 | Why? |
| Societies, Medical | 1 | 2019 | 6907 | 0.01 | Why? |
| Aged | 5 | 2020 | 215776 | 0.01 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 449 | 0.01 | Why? |
| Protein Binding | 1 | 2018 | 11430 | 0.01 | Why? |
| Europe | 1 | 2018 | 12702 | 0.01 | Why? |
| Adult | 5 | 2020 | 244371 | 0.01 | Why? |
| DNA Primers | 1 | 2005 | 1170 | 0.01 | Why? |
| Gene Frequency | 1 | 2005 | 1210 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2019 | 10649 | 0.01 | Why? |
| Drug Therapy, Combination | 1 | 2013 | 7268 | 0.01 | Why? |
| Disease Management | 1 | 2017 | 6841 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2017 | 7330 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.01 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.01 | Why? |
| Phenotype | 1 | 2005 | 4037 | 0.01 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 2005 | 6740 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
| Risk Factors | 1 | 2017 | 71621 | 0.01 | Why? |
| Case-Control Studies | 1 | 2005 | 17671 | 0.00 | Why? |
| Child | 1 | 2013 | 70012 | 0.00 | Why? |
Jakob's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(130)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(335)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_